This page is part of the FHIR Specification (v4.2.0: R5 Preview #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile Ingredient.
Generated Narrative with Details
id: example
role: ActiveBase (Details : {http://ema.europa.eu/example/ingredientRole code 'ActiveBase' = 'ActiveBase)
manufacturer: Organization/example
- | Code[x] | Group |
* | equixabanCompanyequixaban1 (Details : {http://ema.europa.eu/example/specifiedSubstance code 'equixabanCompanyequixaban1' = 'equixabanCompanyequixaban1) | 2 (Details : {http://ema.europa.eu/example/specifiedSubstanceGroup code '2' = '2) |
substance
code: EQUIXABAN (Details : {http://ema.europa.eu/example/substance code 'EQUIXABAN' = 'EQUIXABAN)
Strengths
- *
Other examples that reference this example:
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.